Amit Ravindra Pantawane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amit Ravindra Pantawane has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Amit Pantawane
Department of Chemistry, National Chung Hsing University, Taichung, Taiwan
1 shared publication- Candra Dwipayana Hamdin
Study Program of Pharmacy, Faculty of Medicine and Health Science, University of Mataram, Jl. Majapahit No. 62, Mataram
1 shared publication Hsin-Ru Wu
Instrumentation Center, MOST, National Tsing Hua University, Hsinchu, Taiwan
1 shared publication- Hsin-Ru Wu
Instrumentation Center, MOST, National Tsing Hua University, Hsinchu 30013, Taiwan
1 shared publication Julakanti Satyanarayana Reddy
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Taiwan
1 shared publication- Julakanti Satyanarayana Reddy
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County 35053, Taiwan
1 shared publication
Latest Publications
- Open Access
- 14 November 2026
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 18 (5) , 498-512
Brucea javanica (L.) Merr Seed Extract Exerts Antihypertensive and Renoprotective Activity in Renovascular Hypertensive Mice Model
BACKGROUND: Renovascular hypertension (RVH) drives excessive renin-angiotensin-aldosterone system (RAAS) activation, oxidative stress, and vascular remodelling, but most of current RVH therapies may not fully prevent the disease progression. Brucea javanica seed is known to contain bioactive compound that modulate RAAS and regulate blood pressure, but their effects on RVH remain unclear. This study was conducted to evaluate the potential of B. javanica seed extract (BJSE) as antihypertensive and renoprotective effects. METHODS: BJSE were profiled using liquid chromatography–high resolution mass spectrometry (LC-HRMS) and antioxidant activity was assessed. Network pharmacology and molecular docking were conducted to identify compound–protein targets. Male BALB/c mice was RVH-induced by renal blood flow restriction surgery and received either: no treatment, captopril, or, 10, 20, 30 mg/kg BW BJSE. Healthy mice were also included as control. Blood pressure, urinalysis, haematology, renal function, gross pathology, and kidney-heart histology were evaluated.RESULTS: Ten major metabolites were identified, including flavonoids, phenolic acids, and terpenoids. Antioxidant assays showed IC50 values of 71.81±0.35 ppm (DPPH), 76.30±0.29 ppm (FRAP), and 49.45±0.26 ppm (ABTS). Network pharmacology revealed five hub genes (matrix metallopeptidase 9 (MMP9), peroxisome proliferator-activated receptor gamma (PPARG), nitric oxide synthase 3 (NOS3), angiotensin-converting enzyme (ACE), estrogen receptor 1 (ESR1)), further molecular docking showed phloretin has the highest potential binding with ACE mapped to RAAS. BJSE dose-dependently reduced systolic blood pressure, proteinuria, blood urea nitrogen (BUN), and creatinine, improved erythrocyte parameters and leukocyte counts, and attenuated renal atrophy, cardiac hypertrophy, and histopathological lesions.CONCLUSION: BJSE significantly reduced blood pressure and improved cardiac and renal histopathological profiles, as well as hematological and urinary parameters associated with renoprotective activity. These effects are achieved suggested due to its antioxidant activity and multi-targeted mechanisms. KEYWORDS: polycystic ovary syndrome, Brucea javanica, network pharmacology, renin-angiotensin-aldosterone system, renovascular hypertension, two-kidney-one-clip
- 14 November 2026
- Published by Secretariat of The Indonesian Biomedical Journal in The Indonesian Biomedical Journal
- Vol. 18 (5) , 498-512
Open AccessBrucea javanica (L.) Merr Seed Extract Exerts Antihypertensive and Renoprotective Activity in Renovascular Hypertensive Mice Model
BACKGROUND: Renovascular hypertension (RVH) drives excessive renin-angiotensin-aldosterone system (RAAS) activation, oxidative stress, and vascular remodelling, but most of current RVH therapies may not fully prevent the disease progression. Brucea javanica seed is known to contain bioactive compound that modulate RAAS and regulate blood pressure, but their effects on RVH remain unclear. This study was conducted to evaluate the potential of B. javanica seed extract (BJSE) as antihypertensive and renoprotective effects. METHODS: BJSE were profiled using liquid chromatography–high resolution mass spectrometry (LC-HRMS) and antioxidant activity was assessed. Network pharmacology and molecular docking were conducted to identify compound–protein targets. Male BALB/c mice was RVH-induced by renal blood flow restriction surgery and received either: no treatment, captopril, or, 10, 20, 30 mg/kg BW BJSE. Healthy mice were also included as control. Blood pressure, urinalysis, haematology, renal function, gross pathology, and kidney-heart histology were evaluated.RESULTS: Ten major metabolites were identified, including flavonoids, phenolic acids, and terpenoids. Antioxidant assays showed IC50 values of 71.81±0.35 ppm (DPPH), 76.30±0.29 ppm (FRAP), and 49.45±0.26 ppm (ABTS). Network pharmacology revealed five hub genes (matrix metallopeptidase 9 (MMP9), peroxisome proliferator-activated receptor gamma (PPARG), nitric oxide synthase 3 (NOS3), angiotensin-converting enzyme (ACE), estrogen receptor 1 (ESR1)), further molecular docking showed phloretin has the highest potential binding with ACE mapped to RAAS. BJSE dose-dependently reduced systolic blood pressure, proteinuria, blood urea nitrogen (BUN), and creatinine, improved erythrocyte parameters and leukocyte counts, and attenuated renal atrophy, cardiac hypertrophy, and histopathological lesions.CONCLUSION: BJSE significantly reduced blood pressure and improved cardiac and renal histopathological profiles, as well as hematological and urinary parameters associated with renoprotective activity. These effects are achieved suggested due to its antioxidant activity and multi-targeted mechanisms. KEYWORDS: polycystic ovary syndrome, Brucea javanica, network pharmacology, renin-angiotensin-aldosterone system, renovascular hypertension, two-kidney-one-clip
- 31 July 2025
- Published by Georg Thieme Verlag KG in Synthesis
Imidazolium-Based Acid Catalysts for Deacetylation and Debenzoylation
Herein, we report a simple and efficient protocol for the deprotection of acetate and benzoate to alcohols, catalyzed by an imidazolium-based acid. Acetate groups were selectively removed while benzoate groups remained intact under mild conditions, and benzoate needed harsher conditions. Notably, this protocol was successfully employed for carbohydrate-building block synthesis in a one-pot strategy, was compatible with different ester protecting groups such as O-Bz, O-Ts, and O-Piv and site-selective deprotection of acetate. The reusable, environmentally benign catalyst enabled smooth operation, resulting in a promising protocol for deprotection.
- 31 July 2025
- Published by Georg Thieme Verlag KG in Synthesis
Imidazolium-Based Acid Catalysts for Deacetylation and Debenzoylation
Herein, we report a simple and efficient protocol for the deprotection of acetate and benzoate to alcohols, catalyzed by an imidazolium-based acid. Acetate groups were selectively removed while benzoate groups remained intact under mild conditions, and benzoate needed harsher conditions. Notably, this protocol was successfully employed for carbohydrate-building block synthesis in a one-pot strategy, was compatible with different ester protecting groups such as O-Bz, O-Ts, and O-Piv and site-selective deprotection of acetate. The reusable, environmentally benign catalyst enabled smooth operation, resulting in a promising protocol for deprotection.
- Open Access
Mild and Efficient Tunable Brønsted Acidic Ionic Liquid Catalyzed O-Acetylation and O-Trimethylsilylation with Trimethylsilyl Acetate (TMSOAc) and Hexamethyldisilazane (HMDS)
This report discloses a mild and efficient O-acetylation using easily accessible TMSOAc as a novel acetyl reagent and O-trimethylsilylation using HMDS for various alcohols catalyzed by tunable Brønsted acidic ionic liquids (TBAILs). Imidazolium-based TBAILs were prepared by a two-step atom-economic reaction and acidities measured by using UV-visible spectroscopy. Both protections for alcohols were accomplished at room temperature with good to excellent yields, while the products and TBAILs were separated by simple work-up for O-silylation and column chromatography for O-acetylation. Notably, with the simple post-process, TBAILs catalyst in this solvent free method easily recovered and recycled several times without significant degradation.
Open AccessMild and Efficient Tunable Brønsted Acidic Ionic Liquid Catalyzed O-Acetylation and O-Trimethylsilylation with Trimethylsilyl Acetate (TMSOAc) and Hexamethyldisilazane (HMDS)
This report discloses a mild and efficient O-acetylation using easily accessible TMSOAc as a novel acetyl reagent and O-trimethylsilylation using HMDS for various alcohols catalyzed by tunable Brønsted acidic ionic liquids (TBAILs). Imidazolium-based TBAILs were prepared by a two-step atom-economic reaction and acidities measured by using UV-visible spectroscopy. Both protections for alcohols were accomplished at room temperature with good to excellent yields, while the products and TBAILs were separated by simple work-up for O-silylation and column chromatography for O-acetylation. Notably, with the simple post-process, TBAILs catalyst in this solvent free method easily recovered and recycled several times without significant degradation.